» Articles » PMID: 34582103

Integration of in Vitro Allergy Test Results and Ratio Analysis for the Diagnosis and Treatment of Allergic Patients (INTEGRA)

Overview
Publisher Wiley
Date 2021 Sep 28
PMID 34582103
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The introduction of molecular diagnosis into routine clinical practice has substantially improved the diagnosis and management of allergic patients by allowing clinicians to precisely identify the allergenic molecule responsible for immunoglobulin E (IgE)-mediated allergies. However, it can be challenging to accurately interpret the results of molecular assays, partly due to the limited evidence base. In this context, a panel of experts with extensive experience in interpreting in vitro measures of total and serum specific IgE reviewed the available scientific evidence. After this review, the panel selected a series of representative case studies to demonstrate how determination of specific and total IgE values and the relationship between them (ratio analysis) can add value to the diagnostic process by more precisely defining the patient's sensitization profile. Finally, the experts developed a series of recommendations on the clinical application of ratio analysis to optimize and complement the classical approach to allergy diagnosis.

Citing Articles

Allergen Testing: A Review of the Indications, Procedures, and Limitations in Ocular Allergy.

Kate A, Shanbhag S, Gattu J, Basu S Clin Rev Allergy Immunol. 2024; 67(1-3):1-20.

PMID: 39276294 DOI: 10.1007/s12016-024-09002-5.


Back to basics: likelihood ratios for olive and grass pollen specific IgE in seasonal allergic rhinitis.

Manzanares B, Gonzalez R, Serrano P, Navas A, Alonso C, Fernandez L Front Allergy. 2023; 4:1241650.

PMID: 37859976 PMC: 10582635. DOI: 10.3389/falgy.2023.1241650.


Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy.

Gonzalez Guzman L, Garcia Robaina J, Barrios Recio J, Escudero Arias E, Linares Mata T, Cervera Aznar R Vaccines (Basel). 2023; 11(5).

PMID: 37243083 PMC: 10222808. DOI: 10.3390/vaccines11050979.


Low Levels Matter: Clinical Relevance of Low Pru p 3 sIgE in Patients With Peach Allergy.

Balsells-Vives S, San Bartolome C, Casas-Saucedo R, Ruano-Zaragoza M, Rius J, Torradeflot M Front Allergy. 2022; 3:868267.

PMID: 35769570 PMC: 9234939. DOI: 10.3389/falgy.2022.868267.


Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA).

Pascal M, Moreno C, Davila I, Tabar A, Bartra J, Labrador M Clin Transl Allergy. 2021; 11(7):e12052.

PMID: 34582103 PMC: 9082998. DOI: 10.1002/clt2.12052.

References
1.
Pola-Bibian B, Dominguez-Ortega J, Vila-Nadal G, Entrala A, Gonzalez-Cavero L, Barranco P . Asthma Exacerbations in a Tertiary Hospital: Clinical Features, Triggers, and Risk Factors for Hospitalization. J Investig Allergol Clin Immunol. 2016; 27(4):238-245. DOI: 10.18176/jiaci.0128. View

2.
Perez-Badia R, Rapp A, Morales C, Sardinero S, Galan C, Garcia-Mozo H . Pollen spectrum and risk of pollen allergy in central Spain. Ann Agric Environ Med. 2010; 17(1):139-51. View

3.
Moreno C, Justicia J, Quiralte J, Moreno-Ancillo A, Iglesias-Cadarso A, Torrecillas M . Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients. Allergy. 2014; 69(10):1357-63. DOI: 10.1111/all.12474. View

4.
Agache I, Bilo M, Braunstahl G, Delgado L, Demoly P, Eigenmann P . In vivo diagnosis of allergic diseases--allergen provocation tests. Allergy. 2015; 70(4):355-65. DOI: 10.1111/all.12586. View

5.
Roxbury C, Lin S . Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma. Otolaryngol Clin North Am. 2017; 50(6):1111-1119. DOI: 10.1016/j.otc.2017.08.011. View